Our prolactin was produced in a fruit fly, but made by people. 👩‍🔬 Featuring perspectives from four Future Fielders, our latest blog post dives into the why and how of producing our latest protein. Read the story 👇 bit.ly/4btdz3P

You asked, we listened - a tag-free version of our prolactin is now available! 🙌 Read the white paper and request a sample: bit.ly/48nYD4n

#Quality Assurance Lead, Qi, champions the #qualityculture at Future Fields. We believe transparency + documentation empowers not only our team, but also our customers in custom protein projects! Learn more about our #Drosophila-based #CDMO platform: tinyurl.com/futurefields

Laine, our Protein Biochemistry Lead 👩‍🔬, optimises the yield & purity of #difficulttoexpress proteins through process development, driving intelligent design of protocols for our customers' #DTEPs. Learn more about our #Drosophila-based #CDMO platform: tinyurl.com/futurefields

Even in the face of the strongest industry headwinds to date, Vow continue to reaffirm my belief in cell ag. Bravo, George Peppou and team - this is HUGE

More than 50% of #recombinantprotein production processes fail at the #expression stage. What makes these proteins so #difficulttoexpress? Our latest blog post dives into 5 intrinsic properties of difficult-to-express proteins (#DTEPs) - read it here: bit.ly/4aKcRic

Looking forward to connecting with innovators at #PEGSummit! Keep an eye out for our poster in the #DifficultToExpress Proteins stream: Future Fields' EntoEngine™: Revolutionizing #RecombinantProtein Production with #Transgenic #Drosophila 🧬🪰 PEGS Summit Cambridge Healthtech Institute

We’re a recipient of the Edmonton Edge Fund! 🎉🙌 Thrilled to have the City of Edmonton's support as we build the next generation of advanced #biomanufacturing right here in #YEG. 🪰 Read more on the fund + #innovation projects happening in the city: bit.ly/3wCu3r2

Excited to collaborate with Unicorn Biotechnologies! The collab aims to combine our sustainable growth factors + 🦄’s Marty cell manuf platform to speed up cellular therapeutics development. Thanks to NRC Canada #IRAP for your advisory services and R&D funding support!🚀#biotech #innovation

It was a pleasure to join Jenthera Therapeutics on stage for #MaRSImpactHealth! 🧬🪰 Thanks for having us, MaRS! 💙 #innovation #CRISPR #biotech #biomanufacturing

How technology is tackling questions that confound modern medicine 🧠🪰🧬 Thanks to Toronto Star MaRS for this piece! Thrilled to be featured alongside FemHealth Insights, Generate:Biomedicines, and Altis Labs 🙌 👇 Read it here: bit.ly/4bUU58k

Can you guess what our next recombinant protein will be? 👀

Announcing our latest product: Recombinant #Interleukin-2! 💙 Our #IL2 is now available for research use. Supporting the pioneers of novel immunotherapies, we're thrilled to play a part in the growing fields of #CART, #CARNK, #TIL, and more. View here 👉 bit.ly/4f7Jo4j

Inter-leukin' good! 👀📸 We’re jazzed about our #interleukin going out the door yesterday. #IL2 is the beginning of more exciting launches to come. 🙌 View our IL-2 here 👉 bit.ly/3SdFQDx

Heartbroken to share the news about Ryan Brodziak, a wonderful member of our tech community, a devoted husband, and a loving father. Ryan and his young son were involved in a serious accident, and their lives have been turned upside down. Let’s come together as a community to

EntoEngine™ in 1 minute ☝️🪰 Same purity and quality as traditional systems, but using a *whole organism* (transgenic #Drosophila) instead of single cells in tanks. The result? Cost-effective multicellular expression at scale. Ask us about our tech 👉 bit.ly/3Mdm3Rs

We dug into some numbers to see how we stack up against other protein expression systems in terms of environmental impact. Studies show that our EntoEngine™ changes the game for sustainable protein production. 🪰🌎 Watch the video below for the results 👇🏭💧

Thanks FiercePharma (Fraiser Kansteiner) for sharing our story! 🙌 Secure #biomanufacturing is crucial now more than ever. We’re pleased to be scaling production with Instar 1.0, our commercial biofactory that is 30Xing production efficiencies for the world. 🪰 bit.ly/3AGBqQ5

Introducing Instar 1.0 🚀, our 6,000 square foot biofactory using fruit flies as sustainable bioreactors 🪰 Co-founder and CEO Matt Anderson-Baron shares what this means for scientists developing the next generation of bioinnovations and medicine: bit.ly/3Cqpjat

Interleukin-10 #IL10 is ready for your lab! 💙 Made in Canada 🍁, in our Green-certified lab 🌍, and with the humble fruit fly 🪰, our recombinant proteins help you do great science without the high economic and environmental price tag. Request sample: bit.ly/3CuyXZB